Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04727216 · ClinicalTrials.gov registry record · NA
Intermittent vs. Continuous Dorsal Root Ganglion Stimulation
A NA study of Pain, Chronic and Pain, Intractable, sponsored by Spine and Pain Institute of New York.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04727216: Active NA study of Pain, Chronic and Pain, Intractable, sponsored by Spine and Pain Institute of New York.
NCT04727216 is a NA study of Pain, Chronic and Pain, Intractable that is active but no longer recruiting, run by Spine and Pain Institute of New York. The registered enrollment target is 15 participants, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04727216, a NA study of Pain, Chronic and Pain, Intractable, is active but no longer recruiting, sponsored by Spine and Pain Institute of New York.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate and compare the therapeutic efficacy of intermittent Dorsal Root Ganglion Stimulation (DRG-S) to standard continuous stimulation in patients with chronic intractable pain
Primary Outcome
Pain Questionnaire - (Scale is 0 to 10 with 0 being no pain and 10 being worst pain imaginable)
Conditions Studied
Interventions
- DEVICE Dorsal Root Ganglion Stimulation (DRG-S)
Study Locations (1)
New York
- Spine and Pain Institute NY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-03-23 |
| Est. Completion | 2021-09-15 |
| Phase | NA |
What the registry record for NCT04727216 still lists
NCT04727216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Dorsal Root Ganglion Stimulation (DRG-S) is the first listed.
NCT04727216 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04727216 about?
NCT04727216 is a clinical study titled "Intermittent vs. Continuous Dorsal Root Ganglion Stimulation". The purpose of this study is to evaluate and compare the therapeutic efficacy of intermittent Dorsal Root Ganglion Stimulation (DRG-S) to standard continuous stimulation in patients with chronic intractable pain
What is the current status of trial NCT04727216?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2021-03-23. Estimated completion is 2021-09-15.
What conditions does trial NCT04727216 study?
This clinical trial studies the following conditions: Pain, Chronic, Pain, Intractable.
What interventions are being tested in trial NCT04727216?
The interventions under investigation include: Dorsal Root Ganglion Stimulation (DRG-S) (DEVICE).
Who is sponsoring clinical trial NCT04727216?
This trial is sponsored by Spine and Pain Institute of New York, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04727216 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04727216's enrollment target sits among peer trials
15 48th of 48 higher than 1 of 48 other Pain, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Pain and Opioid Management in Older Adults
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI